Insulin resistance: definition and consequences

被引:414
作者
Lebovitz, HE [1 ]
机构
[1] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA
关键词
insulin action; visceral obesity; fetal malnutrition; syndrome X; free fatty acids;
D O I
10.1055/s-2001-18576
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin resistance is defined clinically as the inability of a known quanity of exogenous or endogenous insulin to increase glucose uptake and utilization in an individual as much as it does in a normal population. Insulin action is the consequence of insulin binding to its plasma membrane receptor and is transmitted through the cell by a series of protein-protein interactions. Two major cascades of protein-protein interactions mediate intracellular insulin action: one pathway is involved in regulating intermediary metabolism and the other plays a role in controlling growth processes and mitoses. The regulation of these two distinct pathways can be dissociated. Indeed, some data suggest that the pathway regulating intermediary metabolism is diminished in type 2 diabetes while that regulating growth processes and mitoses is normal. - Several mechanisms have been proposed as possible causes underlying the development of insulin resistance and the insulin resistance syndrome. These include: (1) genetic abnormalities of one or more proteins of the insulin action cascade (2) fetal malnutrition (3) increases in visceral adiposity. Insulin resistance occurs as part of a cluster of cardiovascular-metabolic abnormalities commonly referred to as "The Insulin Resistance Syndrome" or "The Metabolic Syndrome". This cluster of abnormalities may lead to the development of type 2 diabetes, accelerated atherosclerosis, hypertension or polycystic ovarian syndrome depending on the genetic background of the individual developing the insulin resistance. - In this context, we need to consider whether insulin resistance should be defined as a disease entity which needs to be diagnosed and treated with specific drugs to improve insulin action.
引用
收藏
页码:S135 / S148
页数:14
相关论文
共 62 条
  • [1] RELATIONSHIPS OF GENERALIZED AND REGIONAL ADIPOSITY TO INSULIN SENSITIVITY IN MEN
    ABATE, N
    GARG, A
    PESHOCK, RM
    STRAYGUNDERSEN, J
    GRUNDY, SM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) : 88 - 98
  • [2] [Anonymous], ENDOCRINOLOGY
  • [3] Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes - A 6-month randomized placebo-controlled dose-response study
    Aronoff, S
    Rosenblatt, S
    Braithwaite, S
    Egan, JW
    Mathisen, AL
    Schneider, RL
    [J]. DIABETES CARE, 2000, 23 (11) : 1605 - 1611
  • [4] DOES INTRAABDOMINAL ADIPOSE-TISSUE IN BLACK-MEN DETERMINE WHETHER NIDDM IS INSULIN-RESISTANT OR INSULIN-SENSITIVE
    BANERJI, MA
    CHAIKEN, RL
    GORDON, D
    KRAL, JG
    LEBOVITZ, HE
    [J]. DIABETES, 1995, 44 (02) : 141 - 146
  • [5] Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men
    Banerji, MA
    Faridi, N
    Atluri, R
    Chaiken, RL
    Lebovitz, HE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) : 137 - 144
  • [6] BANERJI MA, 1995, INT J OBESITY, V19, P846
  • [7] INSULIN-SENSITIVE AND INSULIN-RESISTANT VARIANTS IN NIDDM
    BANERJI, MA
    LEBOVITZ, HE
    [J]. DIABETES, 1989, 38 (06) : 784 - 792
  • [8] Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects
    Banerji, MA
    Lebowitz, J
    Chaiken, RL
    Gordon, D
    Kral, JG
    Lebovitz, HE
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (02): : E425 - E432
  • [9] TYPE 2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS, HYPERTENSION AND HYPERLIPEMIA (SYNDROME-X) - RELATION TO REDUCED FETAL GROWTH
    BARKER, DJP
    HALES, CN
    FALL, CHD
    OSMOND, C
    PHIPPS, K
    CLARK, PMS
    [J]. DIABETOLOGIA, 1993, 36 (01) : 62 - 67
  • [10] BARKER DJP, 1989, LANCET, V2, P577